Salk Institute researchers have developed a new compound that acts like a master reset switch in the intestines. In a new study, the compound, called FexD, is found to prevent and reverse intestinal inflammation in mouse models of inflammatory bowel disease. New therapeutic has the potential to treat inflammatory bowel disease by targeting a molecule that keeps order in the intestines. Salk Institute scientists have developed a new drug that acts like a master reset switch in the gut. Called FexD, the compound has previously been found to burn fat, lower cholesterol, and ward off colorectal cancer in mice. Now,...